Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis | Zendy

Claudia Albertini | Zendy; Alessandra Salerno | Zendy; Silvia Atzeni | Zendy; Elisa Uliassi | Zendy; Francesca Massenzio | Zendy; Annalisa Maruca | Zendy; Roberta Rocca | Zendy; Marko Mecava | Zendy; Filomena Silva | Zendy; Débora Mena | Zendy; Pedro Afonso Valente | Zendy; Ana I. Duarte | Zendy; Daniel Chavarria | Zendy; Maicol Bissaro | Zendy; Stefano Moro | Zendy; Stephanie Federico | Zendy; Giampiero Spalluto | Zendy; Ondřej Soukup | Zendy; Fernanda Borges | Zendy; Stefano Alcaro | Zendy; Barbara Monti | Zendy; Paulo J. Oliveira | Zendy; J. Carlos Menéndez | Zendy; María Laura Bolognesi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis

Author(s) -

Claudia Albertini,

Alessandra Salerno,

Silvia Atzeni,

Elisa Uliassi,

Francesca Massenzio,

Annalisa Maruca,

Roberta Rocca,

Marko Mecava,

Filomena Silva,

Débora Mena,

Pedro Afonso Valente,

Ana I. Duarte,

Daniel Chavarria,

Maicol Bissaro,

Stefano Moro,

Stephanie Federico,

Giampiero Spalluto,

Ondřej Soukup,

Fernanda Borges,

Stefano Alcaro,

Barbara Monti,

Paulo J. Oliveira,

J. Carlos Menéndez,

María Laura Bolognesi

Publication year - 2022

Publication title -

acs chemical neuroscience

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.158

H-Index - 69

ISSN - 1948-7193

DOI - 10.1021/acschemneuro.2c00261

Subject(s) - riluzole , rasagiline , excitotoxicity , amyotrophic lateral sclerosis , neuroprotection , in silico , pharmacology , edaravone , chemistry , oxidative stress , neuroscience , glutamate receptor , medicine , biology , parkinson's disease , biochemistry , receptor , disease , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research